You are here

  • Home
  • Archive
  • Volume 60, Issue 5
  • UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

Article metrics

Article menu

Download PDFPDF

Position statement
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022863831339
Dec 2022602597225
Jan 2023566570158
Feb 2023370364104
Mar 2023452428145
Apr 2023581579178
May 2023553527132
Jun 2023279270102
Jul 202323622572
Aug 2023301292110
Sep 202345745052
Oct 202351149085
Nov 2023611586118
Dec 202319118091
Jan 202420918589
Feb 202424623391
Mar 2024362348160
Total739071552251